Minimally-Invasive Catheter-Based Ultrasound for Precision Tumor Ablation in Lung
Award last edited on: 3/13/20

Sponsored Program
Awarding Agency
Total Award Amount
Award Phase
Solicitation Topic Code

Principal Investigator
Everette C Burdette

Company Information

Acoustic MedSystems Inc (AKA: Acoustx)

208 Burwash Avenue
Savoy, IL 61874
   (217) 239-0900
Location: Single
Congr. District: 13
County: Champaign

Phase I

Contract Number: 1R43CA236065-01A1
Start Date: 4/1/19    Completed: 3/31/20
Phase I year
Phase I Amount
Lung and bronchial cancers remain the leading cause of cancer related deaths in both men and women worldwide. CT-guided percutaneous RF and MW thermal ablation has been shown to provide local control and survival benefit for treatment of small lung tumors, but with limitations imposed upon treatable or accessible regions, lack of spatial and dynamic control of ablative therapy to effectively destroy larger tumors, and frequent complications such as pneumothorax. There remains a substantial and unmet clinical need for a minimally-invasive technology for ablation of pulmonary tumors which can produce more consistent and larger conformal ablation zones, access more tumor sites in a less invasive fashion, while under real-time image guidance. Specifically, tumor in the lung surrounded by air filled lung parenchyma is thermally insulated and will require less energy for a given volume of ablation. Catheter-based ultrasound (CBUS) is a novel thermal therapy technology with potential for dynamic and conformal spatial control of ablation, has effective energy penetration, and is delivered under CT-fluoro image guidance for real-time treatment targeting and delivery. In this proposal we plan to develop and establish the feasibility of catheter-based ultrasound technologies specific for lung tumor ablation using CT-fluoro guidance. Building upon the expertise of our group, we pose that catheter-based ultrasound devices can be developed to provide a technique for endobronchial or intraluminal treatment of lung tumors adjacent to central and peripheral airways, respectively, as well as small interstitial devices for a percutaneous approach. Favorable energy penetration across the bronchial wall and preferential absorption and reflection of ultrasound energy at the tumor margin preferentially localizes therapy within tumor and nearby surrounding margin, with larger volume heating possible. The objectives of this project are to (1) perform proof-of-concept development and determine feasibility of high-intensity endobronchial and percutaneous ultrasound for image guided thermal treatment of lung tumors and also minimize percutaneous device size while retaining volume ablation, (2) perform 3D anatomical biothermal simulation studies toward applicator design and development of therapy delivery strategies, (3) implement new devices and demonstrate targeting within lung tumor alone for guidance of catheter-based ultrasonic ablation, and perform in situ evaluations of the endobronchial and percutaneous ultrasound catheters under MDCT image guidance in a porcine model, applying delivery strategies and techniques as developed herein. We anticipate that given a positive outcome of this exploratory study, the devices and imaging techniques can be further developed and evaluated more extensively in animal trials and eventual human pilot studies. Significant potential advantages of this technology include less invasive endobronchial and intraluminal access to more tumor sites, precision ablation of larger volumes, real-time control and treatment verification, thus improving response, reducing complications, and benefiting a greater number of patients.

Public Health Relevance Statement:
Project Narrative Lung and bronchial cancers remain the leading cause of cancer related deaths in both men and women worldwide. The standard treatment for early-stage disease, and select metastatic tumors, is surgical resection. For patients with unresectable tumors or are poor surgical candidates, alternative treatment options include radiotherapy, chemotherapy, and image-guided ablation with radio-frequency (RF), microwave (MW), laser or cryotherapy. Lack of volumetric and directional spatial distribution control of heating, most notably with RF, can limit the dimensions of tumors that can be treated effectively. Percutaneous ablation of tumors near the central/upper lung and airways is often contraindicated due to the presence of critical structures within the needle trajectory. We propose exploratory studies to establish the feasibility of using novel minimally invasive catheter-based therapeutic ultrasound devices with directional and conformal energy pattern capability to provide controlled thermal ablation in lung tumors under CT-fluoroscopic guidance. This approach can provide a precise and less invasive technique for ablation of lung tumors compared to existing methods, thus improving clinical response and benefiting a greater number of patients.

Project Terms:
3-Dimensional; Ablation; absorption; Acoustics; Air; alternative treatment; Anatomy; Animals; Atelectasis; base; Bronchogenic Carcinoma; Cadaver; Cancer Etiology; Catheters; Cessation of life; chemotherapy; Clinical; Cold Therapy; Complication; Coupling; design; Development; Devices; Dimensions; Disease; Dose; dosimetry; Early treatment; Evaluation; Excision; Family suidae; Feedback; Floods; Fluoroscopy; Heating; Human; image guided; Imaging Techniques; improved; In Situ; indexing; interstitial; Irrigation; Lasers; Lesion; Local Therapy; Location; Lung; Lung Neoplasms; Malignant neoplasm of lung; Measurement; men; Methods; microwave electromagnetic radiation; minimally invasive; Modeling; Monitor; Needles; Neoplasm Metastasis; novel; Operative Surgical Procedures; Outcome; Pathology; Pathway interactions; Patients; Pattern; Penetration; Performance; Peripheral; Phase; Pilot Projects; Pneumothorax; Positioning Attribute; prevent; Radiation therapy; radio frequency; real-time images; response; Saline; simulation; Site; Spatial Distribution; standard care; Structure; Structure of parenchyma of lung; targeted delivery; Techniques; Technology; Temperature; Therapeutic; therapy development; Thermal Ablation Therapy; Time; Tissues; Transducers; Tubular formation; tumor; tumor ablation; Tumor Volume; Ultrasonic Therapy; Ultrasonics; Ultrasonography; Unresectable; Woman

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
Phase II Amount